Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-27

Clinical Trial Update: A Study of Oral Seltorexant as an add-on Medication to an Antidepressant on On-road Driving Performance in Participants With Major Depressive Disorder [Phase 1]

View source ↗

Summary

This Phase 1 study has completed. It evaluated oral Seltorexant as an add-on to antidepressant therapy to assess on-road driving performance in adults with majo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Seltorexant (seltorexant)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Depressive Disorder, Major | Phase 1 | Status: COMPLETED